AU Patent

AU2024259356A1 — Lipid nanoparticle (lnp) delivery systems and formulations

Assigned to Prime Medicine Inc · Expires 2025-11-06 · 1y expired

What this patent protects

The present disclosure describes compositions, nanoparticles (such as lipid nanoparticles), and/or lipid nanoparticle compositions and methods of their use.

USPTO Abstract

The present disclosure describes compositions, nanoparticles (such as lipid nanoparticles), and/or lipid nanoparticle compositions and methods of their use.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024259356A1
Jurisdiction
AU
Classification
—
Expires
2025-11-06
Drug substance claim
No
Drug product claim
No
Assignee
Prime Medicine Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.